Schroder Investment Management Group Royalty Pharma PLC Transaction History

Schroder Investment Management Group

$112 Billion
Q2 2025

A detailed history of Schroder Investment Management Group transactions in Royalty Pharma PLC stock. As of the latest transaction made, Schroder Investment Management Group holds 225,514 shares of RPRX stock, worth $8.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

225,514

Previous 98,065 129.96%

Holding current value

$8.2 Million

Previous $3.05 Million 166.22%

% of portfolio

0.01%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$30.85 - $36.14 $3.93 Million - $4.61 Million	127,449 Added 129.96%	225,514 $8.13 Million
Q1 2025 May 13, 2025	SELL	$25.75 - $33.86 $2.53 Million - $3.33 Million	-98,294 Reduced 50.06%	98,065 $3.05 Million
Q4 2024 Feb 12, 2025	SELL	$24.28 - $28.39 $8.61 Million - $10.1 Million	-354,483 Reduced 64.35%	196,359 $5.01 Million
Q3 2024 Nov 13, 2024	BUY	$25.63 - $29.27 $66,176 - $75,575	2,582 Added 0.47%	550,842 $15.6 Million
Q2 2024 Aug 12, 2024	SELL	$26.26 - $29.9 $129,671 - $147,646	-4,938 Reduced 0.89%	548,260 $14.5 Million
Q1 2024 May 14, 2024	BUY	$27.46 - $31.33 $12.4 Million - $14.2 Million	451,942 Added 446.34%	553,198 $16.8 Million
Q4 2023 Feb 13, 2024	BUY	$26.21 - $29.22 $2.32 Million - $2.59 Million	88,678 Added 705.02%	101,256 $2.84 Million
Q3 2023 Nov 14, 2023	SELL	$26.26 - $31.38 $5.76 Million - $6.88 Million	-219,241 Reduced 94.57%	12,578 $341,000
Q2 2023 Aug 11, 2023	BUY	$29.6 - $36.56 $86,550 - $106,901	2,924 Added 1.28%	231,819 $7.13 Million
Q1 2023 May 11, 2023	SELL	$32.77 - $39.4 $10,453 - $12,568	-319 Reduced 0.14%	228,895 $8.25 Million
Q4 2022 Feb 10, 2023	BUY	$39.17 - $44.04 $570,041 - $640,914	14,553 Added 6.78%	229,214 $9.06 Million
Q3 2022 Nov 10, 2022	SELL	$39.88 - $44.65 $649,764 - $727,482	-16,293 Reduced 7.05%	214,661 $8.63 Million
Q2 2022 Aug 11, 2022	BUY	$37.53 - $44.22 $1.36 Million - $1.6 Million	36,105 Added 18.53%	230,954 $9.72 Million
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $1.03 Million - $1.17 Million	27,517 Added 16.44%	194,849 $7.6 Million
Q4 2021 Feb 14, 2022	BUY	$35.17 - $42.48 $837,116 - $1.01 Million	23,802 Added 16.58%	167,332 $6.67 Million
Q3 2021 Nov 12, 2021	SELL	$36.14 - $42.24 $50,523 - $59,051	-1,398 Reduced 0.96%	143,530 $5.19 Million
Q2 2021 Aug 13, 2021	BUY	$39.85 - $46.63 $115,325 - $134,947	2,894 Added 2.04%	144,928 $5.94 Million
Q1 2021 May 17, 2021	BUY	$42.34 - $52.82 $836,299 - $1.04 Million	19,752 Added 16.15%	142,034 $6.2 Million
Q4 2020 Feb 16, 2021	SELL	$36.12 - $50.05 $68,158 - $94,444	-1,887 Reduced 1.52%	122,282 $6.12 Million
Q3 2020 Nov 13, 2020	BUY	$38.56 - $48.36 $1.02 Million - $1.28 Million	26,563 Added 27.21%	124,169 $5.27 Million
Q2 2020 Aug 13, 2020	BUY	$44.5 - $52.11 $4.34 Million - $5.09 Million	97,606 New	97,606 $4.74 Million

Others Institutions Holding RPRX

# of Institutions

496

Shares Held

306M

Call Options Held

1.99M

Put Options Held

384K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $15.9B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.

Account

Schroder Investment Management Group Royalty Pharma PLC Transaction History